Insights

Innovative Cell Therapies ArsenalBio specializes in programmable, CRISPR-enabled cell therapies aimed at solid tumors, presenting opportunities to collaborate on advanced gene editing solutions, manufacturing technologies, and therapeutics development for next-generation cancer treatments.

Strategic Partnerships The company’s ongoing collaborations with Thermo Fisher Scientific and Genentech highlight its focus on scalable manufacturing and cutting-edge T cell therapies, indicating potential for sales of bioprocessing systems, research reagents, and contract manufacturing services.

Recent Funding & Growth With significant recent investment and a revenue range of $100M to $250M, ArsenalBio is expanding its pipeline and infrastructure, creating opportunities to offer innovative research tools, clinical trial support, and capital equipment tailored to expanding biotech needs.

Industry Engagement Participation in major events such as the J.P. Morgan Healthcare Conference suggests a proactive approach to visibility and networking, ideal for sales teams targeting key decision-makers in biotech and pharma sectors interested in advanced cell therapies.

Market Expansion Potential As ArsenalBio develops multi-functional and next-generation T cell therapies for solid tumors, there is a strong opportunity to provide complementary technologies, consultancy, and regulatory support to accelerate their market entry and clinical development efforts.

ArsenalBio Tech Stack

ArsenalBio uses 8 technology products and services including Veeva Vault, GitLab, Windows Server, and more. Explore ArsenalBio's tech stack below.

  • Veeva Vault
    Enterprise Content Management
  • GitLab
    Issue Trackers
  • Windows Server
    Operating Systems
  • Priority Hints
    Performance
  • Smartsheet
    Project Management
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics

Media & News

ArsenalBio's Email Address Formats

ArsenalBio uses at least 1 format(s):
ArsenalBio Email FormatsExamplePercentage
FLast@arsenalbio.comJDoe@arsenalbio.com
88%
Last@arsenalbio.comDoe@arsenalbio.com
7%
First@arsenalbio.comJohn@arsenalbio.com
4%
FL@arsenalbio.comJD@arsenalbio.com
1%

Frequently Asked Questions

Where is ArsenalBio's headquarters located?

Minus sign iconPlus sign icon
ArsenalBio's main headquarters is located at South San Francisco, California 94080 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is ArsenalBio's official website and social media links?

Minus sign iconPlus sign icon
ArsenalBio's official website is arsenalbio.com and has social profiles on LinkedIn.

What is ArsenalBio's SIC code NAICS code?

Minus sign iconPlus sign icon
ArsenalBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ArsenalBio have currently?

Minus sign iconPlus sign icon
As of March 2026, ArsenalBio has approximately 204 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer: N. H.Chief Financial Officer: J. S.Vice President Of Quality: P. H.. Explore ArsenalBio's employee directory with LeadIQ.

What industry does ArsenalBio belong to?

Minus sign iconPlus sign icon
ArsenalBio operates in the Biotechnology Research industry.

What technology does ArsenalBio use?

Minus sign iconPlus sign icon
ArsenalBio's tech stack includes Veeva VaultGitLabWindows ServerPriority HintsSmartsheetYoast SEOGoogle Tag ManagerGoogle Analytics.

What is ArsenalBio's email format?

Minus sign iconPlus sign icon
ArsenalBio's email format typically follows the pattern of FLast@arsenalbio.com. Find more ArsenalBio email formats with LeadIQ.

How much funding has ArsenalBio raised to date?

Minus sign iconPlus sign icon
As of March 2026, ArsenalBio has raised $85M in funding. The last funding round occurred on Oct 17, 2019 for $85M.

When was ArsenalBio founded?

Minus sign iconPlus sign icon
ArsenalBio was founded in 2019.

ArsenalBio

Biotechnology ResearchCalifornia, United States201-500 Employees

ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.

Section iconCompany Overview

Headquarters
South San Francisco, California 94080 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $85M

    ArsenalBio has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $100M$250M

    ArsenalBio's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $85M

    ArsenalBio has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $100M$250M

    ArsenalBio's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.